Embracing the pros and cons of the new weight loss medications (Semaglutide, Tirzepatide, Etc.)
Sheffield-Moore M, Wiktorowicz JE, Soman KV, Danesi CP, Kinsky MP, Dillon EL, Randolph KM, Casperson SL, Gore DC, Horstman AM, Lynch JP, Doucet BM, Mettler JA, Ryder JW, Ploutz-Snyder LL, Hsu JW, Jahoor F, Jennings K, White GR, McCammon SD, Durham WJ
Keep reading Published on: November 09, 2021 Wellstar Clinical Partners Medicare ACO Significantly Reduces Cost for Patients The Centers for Medicare & Medicaid Services (CMS) announced the 2020 results for the Medicare Shared Savings Program (MSSP) and Wellstar Clinical Partners (WCP) Medicare Accountable Care Organization (ACO) helped CMS save over $18 million for the entire performance year
The GLP-1 receptor effect on gut motility GLP-1 receptor activation is the primary driver of gastrointestinal side effects in retatrutide, just as it is in pure GLP-1 agonists like semaglutide and dual agonists like tirzepatide